Drug survival time on anti-TNF agents: Does prior anti-TNF use influence RA outcomes?

被引：0
|
作者：
Kishimoto, M
Greenberg, J
Abramson, SB
Harrington, T
Olenginski, TP
Kafka, SP
Reed, G
Hinkle, K
Kremer, J
Cohen, SB
机构：
[1] NYU, Hosp Joint Dis, New York, NY USA
[2] Geisinger Med Ctr, Danville, PA USA
[3] Clin Res Ctr, Duncansville, PA USA
[4] Univ Massachusetts, Worcester, MA 01605 USA
[5] Ctr Rheumatol, Albany, NY USA
[6] Radiant Res Dallas, Dallas, TX USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [41] Lymphoma associated with thiopurines and/or anti-TNF agents
    Reactions Weekly, 2017, 1678 (1) : 7 - 7
  • [42] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [43] Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type
    Kanis, Shannon L.
    de Lima-Karagiannis, Alison
    van der Ent, Cokkie
    Rizopoulos, Dimitris
    van der Woude, C. Janneke
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (08): : 939 - 947
  • [44] Anti-TNF Agents Induce Alternative Macrophages
    Degboe, Yannick
    Rauwel, Benjamin
    Baron, Michel
    Boyer, Jean Frederic
    Cantagrel, Alain
    Constantin, Arnaud
    Davignon, Jean-Luc
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [45] An Update on Anti-TNF Agents in Ulcerative Colitis
    Samaan, Mark A.
    Bagi, Preet
    Vande Casteele, Niels
    D'Haens, Geert R.
    Levesque, Barrett G.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 479 - +
  • [46] Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients
    Du Pan, Sophie Martin
    Scherer, Almut
    Gabay, Cem
    Finckh, Axel
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 997 - 999
  • [47] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
    Cheifetz, Adam S.
    Abreu, Maria T.
    Flier, Sarah N.
    Papamichail, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
  • [48] Predicting Response to Anti-TNF Treatment in RA Patients
    Middleton, D.
    Harvie, J.
    Steven, M.
    SCOTTISH MEDICAL JOURNAL, 2010, 55 (01) : 43 - 43
  • [49] Use of anti-TNF drug levels to optimise patient management
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    FRONTLINE GASTROENTEROLOGY, 2016, 7 (04) : 289 - 300
  • [50] ANTI-TNFα ANTIBODY VERSUS NON-ANTI-TNFα MOLECULAR AGENTS FOR ULCERATIVE COLITIS PATIENTS WHO FAILED INITIAL ANTI-TNFα THERAPY
    Kanayama, Kengo
    Kato, Jun
    Shiratori, Wataru
    Nagashima, Ariki
    Ohta, Yuki
    Taida, Takashi
    Saito, Keiko
    Goto, Chihiro
    Kurosugi, Akane
    Ishikawa, Tsubasa
    Kaneko, Tatsuya
    Akizue, Naoki
    Okimoto, Kenichiro
    Matsumura, Tomoaki
    Kato, Naoya
    GASTROENTEROLOGY, 2022, 162 (07) : S1098 - S1098
12345